Adjuvant intralesional and systemic Corynebacterium parvum immunotherapy for surgically treated head and neck cancer.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000601:surgery / Q000628:therapy*; D006258:Head and Neck Neoplasms / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D011425:Propionibacterium acnes / Q000276:immunology*; D011897:Random Allocation
D000276:Adjuvants, Immunologic